Although these medications contain the same active ingredient, their approved indications and dosing differ based on formulation and strength
We want to be transparent about where the research stands
When we get older, there's no doubt that the risks of heart attacks and strokes becomes increased, Lee told NPR
Calories: 360390 Protein: 3035g GLP-1 Tip: Soy milk adds protein without extra thickness
Other agencies, including the Australian Competition and Consumer Commission and the Australian Communications and Media Authority, are also involved in tackling scams and misleading online promotions targeting consumers seeking weight-loss treatments.
Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate